Neng Nana

Beyond the Stigma: Understanding and Confronting Male Breast Cancer in Canada beyond-the-stigma-understanding-and-confronting-male-breast-cancer-in-canada-7

Beyond the Stigma: Understanding and Confronting Male Breast Cancer in Canada

Neng Nana October 22, 2026

To many, the diagnosis of breast cancer feels exclusively tied to the female experience. It is a...

Unraveling Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Tumors Hijack the Immune System to Fuel Growth unraveling-cancers-devious-strategy-ou-researchers-discover-how-aggressive-tumors-hijack-the-immune-system-to-fuel-growth

Unraveling Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Tumors Hijack the Immune System to Fuel Growth

Neng Nana October 21, 2026

NORMAN, OK – In a significant breakthrough poised to redefine our understanding of cancer progression and treatment,...

A Global Beacon for the Forgotten Stage: 325 Landmarks to #LightUpMBC for Metastatic Breast Cancer Awareness

Neng Nana October 21, 2026

NEW YORK, NY — As the calendar turns to October, the world is traditionally bathed in a...

A Fractured Partnership: Assessing the Strained Relationship Between the U.S. and the World Health Organization $a-fractured-partnership-assessing-the-strained-relationship-between-the-u-s-and-the-world-health-organization$

A Fractured Partnership: Assessing the Strained Relationship Between the U.S. and the World Health Organization

Neng Nana October 21, 2026

Introduction: A History of Collaboration Under Threat For over seven decades, the United States has stood as...

ESMO 2026: Hutchmed and AstraZeneca Unveil Promising Outlook for Non-Small Cell Lung Cancer Treatment esmo-2026-hutchmed-and-astrazeneca-unveil-promising-outlook-for-non-small-cell-lung-cancer-treatment

ESMO 2026: Hutchmed and AstraZeneca Unveil Promising Outlook for Non-Small Cell Lung Cancer Treatment

Neng Nana October 20, 2026

Introduction The annual European Society for Medical Oncology (ESMO) congress serves as a pivotal platform for showcasing...

From Rejection to Redemption: Disc Medicine’s Bitopertin Poised for FDA Comeback from-rejection-to-redemption-disc-medicines-bitopertin-poised-for-fda-comeback

From Rejection to Redemption: Disc Medicine’s Bitopertin Poised for FDA Comeback

Neng Nana October 19, 2026

In a dramatic reversal of fortune for the biotech sector, Disc Medicine has announced a pivotal success...

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research navigating-the-intersection-of-glp-1-medications-and-breast-cancer-a-deep-dive-into-emerging-research-1

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research

Neng Nana October 19, 2026

By Douglas Feil, NBCF Chief Program Officer The landscape of chronic disease management is rapidly evolving, with...

Beyond the Treatment Room: Navigating the Physical and Emotional Landscape of Life After Breast Cancer beyond-the-treatment-room-navigating-the-physical-and-emotional-landscape-of-life-after-breast-cancer

Beyond the Treatment Room: Navigating the Physical and Emotional Landscape of Life After Breast Cancer

Neng Nana October 19, 2026

The conclusion of breast cancer treatment is a milestone often greeted with a complex mixture of relief,...

Navigating the Orphan Frontier: The FDA’s Ambitious New Rare Disease Framework Initiative navigating-the-orphan-frontier-the-fdas-ambitious-new-rare-disease-framework-initiative-2

Navigating the Orphan Frontier: The FDA’s Ambitious New Rare Disease Framework Initiative

Neng Nana October 17, 2026

In a move signaling a potential sea change for the biotechnology and pharmaceutical sectors, the U.S. Food...

The Fractured Alliance: A Deep Dive into the WHO-U.S. Withdrawal Dispute $the-fractured-alliance-a-deep-dive-into-the-who-u-s-withdrawal-dispute$

The Fractured Alliance: A Deep Dive into the WHO-U.S. Withdrawal Dispute

Neng Nana October 17, 2026

Introduction The relationship between the United States and the World Health Organization (WHO) has long served as...

Beyond the Stigma: Understanding and Confronting Male Breast Cancer in Canada

Unraveling Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Tumors Hijack the Immune System to Fuel Growth

A Global Beacon for the Forgotten Stage: 325 Landmarks to #LightUpMBC for Metastatic Breast Cancer Awareness

A Fractured Partnership: Assessing the Strained Relationship Between the U.S. and the World Health Organization

ESMO 2026: Hutchmed and AstraZeneca Unveil Promising Outlook for Non-Small Cell Lung Cancer Treatment

From Rejection to Redemption: Disc Medicine’s Bitopertin Poised for FDA Comeback

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research

Beyond the Treatment Room: Navigating the Physical and Emotional Landscape of Life After Breast Cancer

Navigating the Orphan Frontier: The FDA’s Ambitious New Rare Disease Framework Initiative

The Fractured Alliance: A Deep Dive into the WHO-U.S. Withdrawal Dispute

You may have missed

A New Trojan Horse: Mount Sinai Scientists Engineer CAR T-Cells to Dismantle Cancer’s Defenses, Offering Hope for Metastatic Tumors

Personalized Cancer Vaccine Shows Promise, But Data Leak Dampens Initial Enthusiasm

Empowering Action: Your Comprehensive Guide to Planning a Meaningful Breast Cancer Awareness Month

Bridging the Gap: How Taylarr Lopez is Redefining Public Health Communications for Equitable Care